Refine by
Analgesic Injection Equipment & Supplies
5 equipment items found
Manufactured by:Lumosa Therapeutics Co., Ltd. based inTaipei, TAIWAN
The WHO estimated that 313 million surgeries are performed each year, and a considerable proportion of patients experience undesirable levels of postoperative pain. A poorly controlled postoperative pain may delay recovery time and the patients may suffer chronic pain that may impair their quality-of-life, causing prolonged duration of opioid use, and higher health-care costs. A US survey showed ...
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
Analgesic efficacy and safety of VVZ-149 injections for post-operative pain following laparoscopic colorectal surgery: a randomized, double-blind, parallel group, placebo-controlled, dose finding ...
Manufactured by:Unisis Corporation Japan based inTokyo, JAPAN
Lineup of Epidural Needles, manufactured with accurate machining and meticulous persistence. Available for both Epirudal Catheter Indwelling and Epidural Block (One-Shot type). We are confident that our needles manufactured under strict quality control with meticulous cares can surely satisfy demand from physicians, by means of quality, reliability and the cost. Variations of length and thickness ...
by:Theralase Technologies Inc. based inToronto, ONTARIO (CANADA)
Theralase Cool Laser Therapy ("CLT") medical devices are clinically indicated and cleared by the Food and Drug Administration (“FDA”) and Health Canada for the safe and effective treatment of knee pain. Theralase CLT devices are used off-label to eliminate pain, reduce inflammation and accelerate tissue healing to treat a broad range of nerve, muscle and joint conditions. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin hydrochloride is development as an injectable ...